CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 126 enrolled
Drug / intervention
Propofol +1 moredrug
Likely dose
Propofol 1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00997126
NCT00997126Phase 4Completed
CompareCT.gov

Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation in the Emergency Department

Hennepin Healthcare Research Institute·interventional·Posted Oct 19, 2009·Updated Jan 27, 2017

In Brief

A Phase 4 clinical trial evaluating Propofol and Alfentanil for Sedation. Completed, enrolled 126 participants across 1 site.

Detailed Summary

This is a clinical trial of propofol and alfentanil as agents for moderated procedural sedation in patients undergoing sedation in the emergency department (ED).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSedation
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2009
Enrollment StartOct 1, 2009
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 16.7 years ago

Interventions

Propofoldrug

Propofol 1 mg/kg IV followed by 0.5 mg/kg prn sedation

Alfentanildrug

Alfentanil 10 ug/kg IV followed by 5 ug/kg prn sedation